X4 Pharmaceuticals's total assets for Q3 2024 were $178.16M, a decrease of -15.41% from the previous quarter. XFOR total liabilities were $118.54M for the fiscal quarter, a 2.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.